AIDXNasdaq United States
Market cap
$5.576 M
$0.46 +0.71%
Close of 7 Aug 2026
Revenue
$2.05M
#3432 by revenue
Earnings
-$3.74M
Loss-making
Shares outstanding
10,611,528
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for 20/20 Biolabs are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.